logo
Winnipeg Transit unveils first zero-emission fuel-cell bus

Winnipeg Transit unveils first zero-emission fuel-cell bus

Yahoo20-02-2025

Winnipeg Transit unveiled its first zero emission bus on Wednesday.
But while the city expects to receive dozens more zero-emission buses over the next few years, supply chain issues, budget pressures and looming tariff threats have thrown the city's plans to phase out its diesel fleet into doubt.
Erin Cooke, manager of Transit's transition to zero-emission bus program, says the city will test two types of buses — hydrogen fuel cell and battery electric — in 40-foot and 60-foot sizes.
The fuel cell bus the city received is the third such vehicle in service in Canada, Cooke said.
"So we're cutting-edge right now, when it comes to technology, for testing this out," Cooke told reporters during a news conference at Transit's Osborne Street garage.
"We do have other zero-emission buses that will be arriving this year, which will include the first 60-foot [electric] buses in Canada, as well as battery electric buses as well."
The buses include a mix of fuel cell electric, which charge with hydrogen, and battery electric, which can be plugged into a charger.
With $280 million from all three levels of government through the Investing in Canada Infrastructure Program, the city expects to purchase a total of 90 zero-emission buses, including 70 battery electric and 20 fuel cell vehicles.
Half of the 16 buses expected this year will be fuel cell, and the other half will be battery electric. Half will be 40 feet in length, and the other half will be 60 feet. The city expects to receive another 24 zero-emission buses next year.
A 40-foot battery electric bus costs around $1.56 million, while a fuel cell bus costs about $1.9 million. A diesel bus costs approximately $900,000.
Hydrogen buses can run for 24 hours, while battery electric buses can run for 10 to 15 hours.
Fuel cell buses are entirely zero-emission, while battery-electric buses must include a small diesel generator to heat the battery in cold weather.
The city participated in a pilot project to test four zero-emission buses from 2015 to 2018.
Zero-emission plans scaled back
The city has already scaled back its plans to purchase more zero-emission buses. It had planned to buy 100 buses with the funding from ICIP, but had to reduce its orders due to supply chain issues and cost pressures.
The 2025 budget includes a directive to resume purchasing diesel buses in 2027.
Public works chair Coun. Janice Lukes isn't sure the city will meet its goal of an all-electric fleet by 2045.
"The city would love to have all electric buses, but unfortunately unless we have other level of government support, we won't be able to afford them," she said.
Cooke says the city could still meet the target.
"As long as we make choices sort of in the 2032 timeline … that target's is still totally achievable," she said.
Josipa Petrunic with the Canadian Urban Transit Research and Innovation Consortium says looming tariffs on U.S. imports from Canada could cut the number of electric buses the city can afford even further.
"Buses get more expensive, and all of a sudden the city that has so much money can buy many fewer buses from what it planned," Petrunic said.
There are currently 632 buses in the city's fleet.
The city says the new buses will begin limited service in April, after the spring schedule change.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Rancho Cucamonga Bets Big on Becoming First US Bullet Train Hub
Rancho Cucamonga Bets Big on Becoming First US Bullet Train Hub

Bloomberg

time18 hours ago

  • Bloomberg

Rancho Cucamonga Bets Big on Becoming First US Bullet Train Hub

Rancho Cucamonga, a car-dependent suburb 40 miles east of Los Angeles, is positioning itself to become America's first bullet train hub when Brightline West's high-speed rail line opens in 2028. The private rail line will connect Southern California and Las Vegas, making Rancho Cucamonga the western terminus of the $12 billion project. The city is planning a dense, walkable urban district around its upcoming rail station, transforming the sprawling commuter town into a transit-oriented destination for the millions of passengers expected to pass through annually, contributor Sarah Stodola reports. Success ultimately hinges on Brightline's ability to meet its ambitious deadline and ridership projections. Today on CityLab: Next Stop: Rancho Cucamonga!

Beyond The Fare: Why Account-Based Ticketing Is A Leadership Move
Beyond The Fare: Why Account-Based Ticketing Is A Leadership Move

Forbes

time19 hours ago

  • Forbes

Beyond The Fare: Why Account-Based Ticketing Is A Leadership Move

Account-Based Ticketing is more than fare tech. It's a leadership tool to unify systems, modernize ... More policy, and build rider trust across transit networks. Nathalie Ricci, executive consultant and founder of PulseCorp, has contributed to this story. I've spent over two decades building and leading intelligent transportation projects across North America and Europe, including as CEO of INIT Inc. in Canada. I had the privilege of spearheading the STM's winning bid for the iBUS project in Montreal in 2012, and I played a hands-on role in the UK's first implementation of Account-Based Ticketing (ABT) for Trent Barton. This isn't theoretical for me. I've seen firsthand how fare systems can either enable smart governance or block progress. That's why I believe ABT is more than another IT upgrade. It's a strategic lever for a modern transit leadership move. Traditional fare systems were built in an era when everything was hard-coded into physical cards. The logic was offline, rigid, and lived on a chip, locked inside plastic. These systems are robust and built for durability, but they have made innovation slow and expensive. What we're seeing now with ABT is a paradigm shift. Instead of encoding fares on a smart card, we assign them to a cloud-based account. The card, or mobile device, bank card, or QR code, becomes just an identifier. The fare logic, policy engine, and data live in the back office. Figure 1: ABT system architecture This shift opens up what I call "real-time flexibility with long-term control." Transit leaders can now pilot fare policy without reissuing cards. Riders can tap any mode, any time, and always get the best fare. And agencies gain live dashboards, cross-operator visibility, and tools to shape behavior. In my experience, ABT enables three core capabilities that transit leaders truly need now: It's not just about tapping faster. It's about governing smarter with the tools to shape ride behavior, plan equitably, and build trust through transparency. Let's be honest: many cities — including mine — are still operating with legacy card-centric systems. The OPUS card widely used across the Greater Montreal area and its surrounding regions, for example, remains fully dependent on stored-value logic. It works, but it can't scale with what riders expect. The system can't adjust fares in real time. It can't unify across services. It can't evolve without major physical upgrades. And here's the leadership challenge: if fare systems can't keep up, mobility strategies fall behind. We can't build a flexible, sustainable, rider-first transit future on foundations that were never designed for it. Account-Based Ticketing is no longer futuristic. Cities like London and Portland have been running ABT systems for years. Canada's most advanced ABT initiative, the Arc card, is already active in Alberta, proving what's possible with a smart, scalable platform. Meanwhile, in regions like Quebec, we remain tied to card-based logic that limits our options and ambitions. If we want our cities to be equitable, sustainable, and competitive, we need to treat fare systems as more than operational tools. And for that, ABT has to be part of the roadmap. For leaders, this is about more than digitizing fare collection. It's about using fare systems as a lever for real mobility governance. Nathalie Ricci, Founder and CEO of PulseCorp Nathalie Ricci is the Founder & CEO of PulseCorp Inc., a Canadian start-up that helps transit leaders at all levels modernize digital mobility. You can visit the PulseCorp website at

DIA to Celebrate 9 Life Sciences Leaders at DIA 2025 Global Annual Meeting in Washington
DIA to Celebrate 9 Life Sciences Leaders at DIA 2025 Global Annual Meeting in Washington

Yahoo

time2 days ago

  • Yahoo

DIA to Celebrate 9 Life Sciences Leaders at DIA 2025 Global Annual Meeting in Washington

EMA's Emer Cooke, former FDA Commissioner Dr. Robert Califf to be recognized among new Fellows of DIA and annual Global Inspire Award winners, with special keynote from global health leader Dr. Larry Brilliant and live performance from Grammy-nominated artist Aloe Blacc WASHINGTON, June 04, 2025--(BUSINESS WIRE)--DIA, a global non-profit organization of life sciences professionals, will induct four Fellows of DIA and recognize six recipients of Global Inspire Awards and America's Inspire Awards on June 15 as part of the DIA 2025 Global Annual Meeting — including Emer Cooke, Executive Director of the European Medicines Agency (EMA), who is receiving both honors. Fellows of DIA are long-serving members recognized for their sustained dedication to advancing healthcare. The Global Inspire Awards recognize honorees who have made outstanding improvements to global health while adhering to DIA's mission. "These distinguished individuals have made enduring contributions to the life sciences reflecting DIA's values and purpose," said Marwan Fathallah, DIA's President and Chief Executive Officer. "Their work in regulatory science, research, and global collaboration exemplifies the spirit of innovation that drives our mission forward." Cooke has been the EMA's Executive Director and the Chair of the International Coalition of Medicines Regulatory Authorities (ICMRA) since November 2020. She has more than 30 years of experience in international regulatory affairs, including four years as the director responsible for medical product-related regulatory activities at the World Health Organization (WHO). Dr. Robert M. Califf, who served as the Commissioner of the U.S. Food and Drug Administration (FDA) from February 2016 to January 2017 and February 2022 to January 2025, is also being recognized as a Fellow of DIA. A nationally recognized expert in cardiovascular medicine and health outcomes research, he has led many landmark clinical trials and is one of the most frequently cited authors in biomedical science. Dr. Califf became a Member of the National Academy of Medicine in 2016. Dr. Michael Rosenblatt and Dr. Hironobu Saito are also being named Fellows of DIA. Rosenblatt, a Senior Partner at Flagship Pioneering and the Immediate Past Chair of DIA's Board of Directors, has advanced biopharmaceutical research and development throughout his career. He was previously Merck's Chief Medical Officer and the Dean of the Tufts University School of Medicine. Saito, a Specially Appointed Professor at Tottori University's Chromosome Engineering Research Center, spent 35 years in drug development at Daiichi Sankyo and has contributed to DIA Japan for more than two decades. In addition to Cooke, who will be presented with the Global Award for Outstanding Contribution to Health, six members of the health and life sciences community will receive Global Inspire Awards: — Kazumichi Kobayashi, Executive Deputy President at Otsuka Medical Device, will be honored with the Global Connector Award for advancing DIA's mission and promoting global collaborations. Kobayashi, who has served in various senior positions in research and development at Otsuka Pharmaceutical Co., previously led DIA Japan and chaired the DIA Advisory Council of Japan. — Cary Smithson will receive the Community Engagement Award as a DIA Community Chair who consistently drives engagement while advancing knowledge and thought leadership. Smithson, a Managing Partner at LeapAhead Solutions, leads DIA's Regulatory Affairs Community and Regulatory Information Management (RIM) Intelligent Automation Team, and co-leads its RIM Working Group. —Jennifer B. Christian will be named the Author of the Year, an award given to individuals whose article made the greatest impact on readership based on the number of downloads reported by Therapeutic Innovation & Regulatory Science (TIRS) in the preceding issue year. Her article, co-authored with Mehmet Burcu, Cyntia B. Manzano-Salgado, Anne M. Butler, "A Framework for Extension Studies Using Real-World Data to Examine Long-Term Safety and Effectiveness," was downloaded more than 12,400 times. Global Inspire Award recipients, except for the Author of the Year, must be nominated by two active DIA members to be considered candidates. They undergo a thorough review process before a committee of Fellows of DIA selects the winners. DIA will also recognize the regional Inspire Awards winners from the Americas: — David Fryrear, Chief Quality Officer at Astellas Pharma, will receive the Excellence in Service Award as a DIA volunteer who has significantly contributed to the advancement of the organization's mission. He previously held senior roles at AbbVie and Eli Lilly and Company and spent much of his career developing and improving quality systems. — Elma Abdulbaki, a PharmD student at the University of Illinois at Chicago and President of the DIA National Student Board, will be honored with the Leader of Tomorrow Award for her outstanding contributions as a young professional in the healthcare field. In addition to these awards and recognitions, there will be a performance by Grammy-nominated artist and songwriter Aloe Blacc. Renowned physician, epidemiologist, and global health leader Dr. Larry Brilliant will keynote at the event. Tickets for the awards ceremony are available to the public for the first time and can be purchased by clicking here. These honors will be presented in conjunction with the DIA 2025 Global Annual Meeting, the world's preeminent multidisciplinary life sciences forum held June 15-19 at the Walter E. Washington Convention Center in Washington. Click here to register or view the DIA 2025 event program. Media members may request credentials by emailing diaglobal@ About DIADIA is a leading global non-profit life science membership association that drives collaboration in drug, device, and diagnostics development in pursuit of a healthier world. Founded in 1964 with headquarters in Washington, D.C., and offices in Europe and Asia, DIA provides unparalleled networking opportunities, educational resources, scientific research publications, and professional development programs to members in more than 80 countries. Learn more at and connect with DIA on LinkedIn, Facebook, X (Twitter), and Instagram. View source version on Contacts Media Katie KennedyGregory FCAdiaglobal@ 610-731-1045 Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store